首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 核酸藥物

市場調查報告書

商品編碼

2073746

核酸治療藥物研發生產機構（CDMO）市場：按類型、服務、最終用途、應用、國家和地區分類－全球產業分析、市場規模及佔有率、未來預測（2026-2033）

Nucleic Acid Therapeutics CDMO Market, By Type, By Service, By End Use, By Application, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

出版日期: 2026年06月24日 | 出版商:

AnalystView Market Insights | 英文 343 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年核酸療法 CDMO（合約開發和受託製造廠商）的市場規模估計為 175.083 億美元，預計從 2026 年到 2033 年將以 14.3% 的複合年成長率成長。

核酸藥物是一類人工合成的寡核苷酸（DNA、RNA 或核苷酸鹼基的類似物），其序列明確，可透過沃森-克里克鹼基配對與目標DNA序列結合。核酸藥物的結構可在骨架（硫代磷酸酯鍵）或醣基單元（2'-O-甲基核酸或鎖核酸）上進行修飾，從而透過反義結合、 RNA干擾或剪接調控來控制目標DNA基因表現。因此，核酸療法能夠實現高度特異性的基因調控，從而為先進的標靶治療策略提供可能。

核酸藥物CDMO的市場動態

RNA療法的快速發展正在推動市場成長。

RNA療法的興起是影響核酸療法CDMO市場發展的主要因素之一，其驅動力在於對RNA藥物研發和生產需求的不斷成長。例如，根據美國國家醫學圖書館（NLM）發表的一篇綜合綜述，到2026年，正如該綜述中詳述的那樣，得益於mRNA、siRNA、ASO和RNA編輯技術的進步，全球將有超過20種RNA藥物獲得批准，另有一些藥物將處於不同的臨床試驗階段，包括I期、II期和III期，用於治療感染疾病、遺傳性疾病、感染性疾病。臨床研發的加速發展顯著提升了全球對專業CDMO服務的需求。

核酸治療藥物研發生產機構（CDMO）市場：細分市場分析

全球核酸療法 CDMO 市場按類型、服務、最終用途、應用和地區進行細分。

在應用領域，感染疾病領域佔據了相當大的佔有率，這主要得益於RNA和DNA藥物生產技術的進步，從而推動了針對病毒、細菌和新型感染疾病的核酸藥物需求的成長。 2025年5月，丹納赫旗下子公司Aldevron與整合式 DNA Technologies合作，利用先進的DNA和RNA生產技術，推出了首個基於mRNA的個人化CRISPR療法。這將有助於開發用於治療遺傳疾病和感染疾病的下一代核酸藥物。預計這一趨勢將進一步加速全球核酸療法的創新和應用。

核酸治療藥物研發生產機構（CDMO）市場－區域分析

北美地區在有利的法規環境、活性化的投資和資金籌措以及產品核可的增加的推動下，引領了核酸療法CDMO市場的發展。例如，根據美國國家科學院、工程院和醫學院提出的「將治療創新投資與疾病負擔和未滿足的需求相匹配」的舉措，到2026年，人們將更加關注加大對解決高優先級健康挑戰和服務不足患者群體的療法的投資。本研究匯集了來自醫療保健、生物製藥和政策領域的16位專家組成的跨學科委員會，旨在評估如何更有效地將研發資金分配給需求最迫切的領域。預計這一投資動能將加速創新並促進區域市場成長。

印度核酸治療藥物研發生產機構（CDMO）市場－國家分析

由於印度擁有成本效益高的生產基礎設施、高素質的勞動力以及符合世界衛生組織現行藥品生產品質管理規範（WHO-cGMP）標準的先進生產設施，預計其核酸治療藥物合約研發生產機構（CDMO）市場將迎來高速成長。例如，根據印度藥品監管局（CDSCO）的數據，目前印度各邦共有2006家獲得WHO-cGMP認證的製藥生產企業，這顯示印度擁有大量一流的WHO-cGMP認證企業。其中，古吉拉突邦以684家WHO-cGMP認證企業位居榜首，其次是馬哈拉斯特拉邦（229家）、喜馬偕爾邦（202家）、特倫甘納邦（172家）和北阿坎德邦（128家）。這一強大的生產基礎使印度成為核酸治療藥物CDMO服務的首選地點。

介紹
北美洲
- 概述
- 主要製造商：北美
- 美國
- 加拿大
歐洲
- 概述
- 主要製造商：歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 瑞典
- 俄羅斯
- 波蘭
- 丹麥
- 其他歐洲國家
亞太地區
- 概述
- 主要製造商：亞太地區
- 中國
- 印度
- 日本
- 韓國
- 澳洲
- 印尼
- 泰國
- 菲律賓
- 台灣
- 越南
- 其他亞太國家
拉丁美洲
- 概述
- 主要製造商：拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 其他拉丁美洲國家
中東和非洲
- 概述
- 主要生產商：中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- 伊朗
- 卡達
- 其他中東和非洲國家

第12章：主要供應商分析：核酸治療藥物CDMO產業

競爭基準
- 競爭對手儀錶板
- 競爭定位
公司簡介
- Agilent Technologies, Inc.
- Curia Global, Inc.
- Ajinomoto Co., Inc.
- Danaher Corporation
- Aldevron
- Integrated DNA Technologies（IDT）
- KNC Laboratories Co., Ltd.
- LGC Limited
- Axolabs GmbH
- Merck KGaA
- WuXi AppTec Co., Ltd.
- BioSpring GmbH
- Univercells Inc.
- Exothera SA
- AGC Biologics, Inc.
- Asymchem Inc.
- Bachem AG
- BioCina
- CMIC HOLDINGS Co., Ltd.
- Eurofins Scientific SE
- Kaneka Corporation
- Others

第13章：使用 AnalystView 進行綜合分析

簡介目錄

Product Code: ANV6849

Nucleic Acid Therapeutics CDMO market size was valued at US$ 17,508.3 Million in 2025, expanding at a CAGR of 14.3% from 2026 to 2033.

The nucleic acid drugs represent a family of artificial oligonucleotides (DNA, RNA, or analogs of nucleotide bases) with a well-defined sequence that will be able to bind with the target DNA sequence through Watson-Crick base pairing. The nucleic acid drug structure, which can undergo modifications to its backbone (phosphorothioate bonds) or sugar units (2'-O-methyl or locked nucleic acids), enables the manipulation of the gene expression of the target DNA by antisense binding, RNA interference, or splice modulation. Thus, nucleic acid therapeutics offer highly specific genetic regulation for advanced targeted treatment strategies.

Nucleic Acid Therapeutics CDMO Market- Market Dynamics

Rapid Expansion of RNA-Based Therapeutics to Drive Market Growth

The rise in RNA-based therapeutic drugs is among the main reasons that impact the development of the Nucleic Acid Therapeutics CDMO market owing to growing demands in the development and manufacturing of these RNA-based drugs. For instance, in 2026, according to a comprehensive review published in the U.S. National Library of Medicine (PMC), because of the advancements in mRNAs, siRNAs, ASOs, and RNA editing as described in detail in the review made by the U.S. National Library of Medicine (PMC). Already over 20 RNA-based drugs have been approved worldwide, while others are at different stages of clinical trials; that is, Phase I, II, and III, for treatments of cancer, genetic diseases, infectious diseases, and metabolic diseases. This accelerating clinical progress is significantly increasing demand for specialized CDMO capabilities worldwide.

Nucleic Acid Therapeutics CDMO Market- Segmentation Analysis:

The Global Nucleic Acid Therapeutics CDMO market is segmented on the basis of Type, Service, End Use, Application, and Region.

Among the given applications, infectious diseases account for a prominent share because of the growing need for nucleic acid drugs for viral, bacterial, and novel infections owing to the advances made in the field of RNA- and DNA-based drug manufacturing. In May 2025, Aldevron, which is a part of Danaher, partnered with Integrated DNA Technologies to introduce the first personalized CRISPR therapy using mRNA through advanced manufacturing technologies for DNA and RNA, contributing to the development of next generation nucleic acid medicines for genetic and infectious diseases. This trend is expected to further accelerate innovation and adoption of nucleic acid therapeutics globally.

Nucleic Acid Therapeutics CDMO Market- Geographical Insights

North America dominated the Nucleic Acid Therapeutics CDMO market due to its supportive regulatory environment, increasing investment and funding activities, and a rising number of product approvals. For instance, in 2026, according to the National Academies of Sciences, Engineering, and Medicine's initiative on aligning investments in therapeutic innovation with disease burden and unmet needs, growing attention is being directed toward increasing investment in therapeutics that address high-priority health challenges and underserved patient populations. The study brings together a multidisciplinary committee of 16 experts from healthcare, biopharmaceuticals, and policy to evaluate how research and development funding can be more effectively allocated toward areas with the greatest unmet medical need. This investment momentum is expected to accelerate innovation and strengthen regional market growth.

India Nucleic Acid Therapeutics CDMO market - Country Insights

The India Nucleic Acid Therapeutics CDMO market is expected to see high levels of growth owing to its cost-effective manufacturing infrastructure, high-caliber workforce, and the presence of high-end WHO-cGMP-compliant manufacturing plants. For instance, according to CDSCO Gov, there are 2,006 WHO-cGMP-certified pharmaceutical manufacturing facilities in India spread throughout different states in the list up till now, which means that India is blessed with many top-class WHO-cGMP manufacturing facilities. Gujarat stands first with 684 WHO-cGMP-certified manufacturing plants, followed by Maharashtra with 229, Himachal Pradesh with 202, Telangana with 172, and Uttarakhand with 128 WHO-cGMP manufacturing facilities. This strong manufacturing base positions India as a preferred hub for nucleic acid therapeutics CDMO services.

Nucleic Acid Therapeutics CDMO Market- Competitive Landscape:

Leading companies in the global market, including LGC Limited, Merck KGaA, WuXi AppTec, BIOSPRING, and Univercells Inc., are putting all their efforts into strategic growth. Such companies have been concentrating on collaborations, acquisitions, capacity expansion, and other service launches that could prove beneficial for their market shares, technologies, and worldwide presence. In October 2025, BIOSPRING launched manufacturing services for Luxna Biotech's unique XNA amidite portfolio that includes AmNA(TM), scpBNA(TM), and 5'-CP(TM) chemistries. The launch of this product line will improve the therapeutic oligonucleotide contract development and manufacturing organization services provided by BIOSPRING due to the advanced nucleic acid medicines with improved affinity, increased stability, and lower toxicity. These moves will increase the speed of innovations of companies operating in the global market.

Recent Developments:

In June 2026, Merck KGaA agreed to acquire Bio-Techne Corporation for approximately USD 11.3 billion, significantly expanding its life science business. The acquisition strengthens Merck's portfolio of research reagents, proteins, antibodies, and analytical tools supporting biopharmaceutical and nucleic acid therapeutics development.

In March 2026, Agilent Technologies launched Agilent Advanced Therapeutics, integrating its nucleic acid manufacturing and CDMO capabilities to provide end-to-end oligonucleotide development and production services supporting advanced therapeutic programs, including infectious disease-focused nucleic acid therapies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Agilent Technologies, Inc.
Curia Global, Inc.
Ajinomoto Co., Inc.
Danaher Corporation
Aldevron
Integrated DNA Technologies (IDT)
KNC Laboratories Co., Ltd.
LGC Limited
Axolabs GmbH
Merck KGaA
WuXi AppTec Co., Ltd.
BioSpring GmbH
Univercells Inc.
Exothera SA
AGC Biologics, Inc.
Asymchem Inc.
Bachem AG
BioCina
CMIC HOLDINGS Co., Ltd.
Eurofins Scientific SE
Kaneka Corporation
Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

Plasmid DNA
Antisense Oligonucleotides
siRNA Therapeutics
mRNA Therapeutics
Gene Therapy
Viral Vector-based Products
Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY SERVICE- MARKET ANALYSIS, 2020 - 2033

Process Development and Optimization
Manufacturing Services
Analytical and Quality Control Services
Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033

Pharmaceutical Companies
Biotech Companies
Government & Academic Research Institutes
Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

Genetic Disorders
Infectious Diseases
Oncology
Metabolic Disorders
Rare Diseases
Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

1. Nucleic Acid Therapeutics CDMO Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Nucleic Acid Therapeutics CDMO Market Snippet by Type
- 2.1.2. Nucleic Acid Therapeutics CDMO Market Snippet by Service
- 2.1.3. Nucleic Acid Therapeutics CDMO Market Snippet by End Use
- 2.1.4. Nucleic Acid Therapeutics CDMO Market Snippet by Application
- 2.1.5. Nucleic Acid Therapeutics CDMO Market Snippet by Country
- 2.1.6. Nucleic Acid Therapeutics CDMO Market Snippet by Region
2.2. Competitive Insights

3. Nucleic Acid Therapeutics CDMO Key Market Trends

3.1. Nucleic Acid Therapeutics CDMO Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Nucleic Acid Therapeutics CDMO Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Nucleic Acid Therapeutics CDMO Market Opportunities
3.4. Nucleic Acid Therapeutics CDMO Market Future Trends

4. Nucleic Acid Therapeutics CDMO Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Nucleic Acid Therapeutics CDMO Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Nucleic Acid Therapeutics CDMO Market Landscape

6.1. Nucleic Acid Therapeutics CDMO Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Nucleic Acid Therapeutics CDMO Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
- 7.1.2. Plasmid DNA
- 7.1.3. Antisense Oligonucleotides
- 7.1.4. siRNA Therapeutics
- 7.1.5. mRNA Therapeutics
- 7.1.6. Gene Therapy
- 7.1.7. Viral Vector-based Products
- 7.1.8. Others

8. Nucleic Acid Therapeutics CDMO Market - By Service

8.1. Overview
- 8.1.1. Segment Share Analysis, By Service, 2025 & 2033 (%)
- 8.1.2. Process Development and Optimization
- 8.1.3. Manufacturing Services
- 8.1.4. Analytical and Quality Control Services
- 8.1.5. Others

9. Nucleic Acid Therapeutics CDMO Market - By End Use

9.1. Overview
- 9.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
- 9.1.2. Pharmaceutical Companies
- 9.1.3. Biotech Companies
- 9.1.4. Government & Academic Research Institutes
- 9.1.5. Others

10. Nucleic Acid Therapeutics CDMO Market - By Application

10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 10.1.2. Genetic Disorders
- 10.1.3. Infectious Diseases
- 10.1.4. Oncology
- 10.1.5. Metabolic Disorders
- 10.1.6. Rara Diseases
- 10.1.7. Others

11. Nucleic Acid Therapeutics CDMO Market - By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.17. Denmark
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.17.4. Denmark Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.17.5. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.17.6. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.18. Rest of Europe
  - 11.3.18.1. Overview
  - 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.18.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.3.18.4. Rest of the Europe Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.3.18.5. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.16. Taiwan
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.16.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.16.4. Taiwan Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.16.5. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.16.6. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.17. Vietnam
  - 11.4.17.1. Overview
  - 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.17.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.17.4. Vietnam Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.17.5. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.17.6. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.18. Rest of APAC
  - 11.4.18.1. Overview
  - 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.18.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.4.18.4. Rest of APAC Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.4.18.5. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.4.18.6. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.14. Iran
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.14.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.14.4. Iran Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.14.5. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.14.6. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.15. Qatar
  - 11.6.15.1. Overview
  - 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.15.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.15.4. Qatar Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.15.5. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.15.6. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.16. Rest of MEA
  - 11.6.16.1. Overview
  - 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.16.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 11.6.16.4. Rest of MEA Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
  - 11.6.16.5. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  - 11.6.16.6. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Nucleic Acid Therapeutics CDMO Industry

12.1. Competitive Benchmarking
- 12.1.1. Competitive Dashboard
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Agilent Technologies, Inc.
- 12.2.2. Curia Global, Inc.
- 12.2.3. Ajinomoto Co., Inc.
- 12.2.4. Danaher Corporation
- 12.2.5. Aldevron
- 12.2.6. Integrated DNA Technologies (IDT)
- 12.2.7. KNC Laboratories Co., Ltd.
- 12.2.8. LGC Limited
- 12.2.9. Axolabs GmbH
- 12.2.10. Merck KGaA
- 12.2.11. WuXi AppTec Co., Ltd.
- 12.2.12. BioSpring GmbH
- 12.2.13. Univercells Inc.
- 12.2.14. Exothera SA
- 12.2.15. AGC Biologics, Inc.
- 12.2.16. Asymchem Inc.
- 12.2.17. Bachem AG
- 12.2.18. BioCina
- 12.2.19. CMIC HOLDINGS Co., Ltd.
- 12.2.20. Eurofins Scientific SE
- 12.2.21. Kaneka Corporation
- 12.2.22. Others